Search - tctmd.com

Displaying 1 - 20 of 138

Sort: Relevancy | Date

Presentation TCT 2025

Case-Based Discussion: Designing a Contemporary Cardiovascular Trial

Presenter: Stephan Windecker

October 27, 2025

Presentation TCT 2024

Impact & Utility of a Global Registry Infrastructure for Device Evidence: ESC Regulatory Affairs Committee Perspective

Presenter: Stephan Windecker

October 29, 2024

Presentation TCT 2024

Globalization of Regulatory Requirements: Challenges & Opportunities - A European Perspective

Presenter: Stephan Windecker

October 28, 2024

Presentation TCT 2024

Breakthroughs In Pharmaceuticals: Antagonistic or Synergistic to Innovation in Device Development

Presenter: Stephan Windecker

October 27, 2024

Presentation TCT 2023

Does Polymer Coating Matter? Biodegradable vs Durable vs Polymer-Free

Presenter: Stephan Windecker

October 26, 2023

Presentation TCT 2023

Perspective: How I See the Future for TAVR in Younger Patients With Bicuspid AS

Presenter: Stephan Windecker

October 24, 2023

News Conference News TCT 2023

Some Surprises in Low-Risk TAVI Follow-up: PARTNER 3 and Evolut Trials

Michael O'Riordan

October 24, 2023

Presentation TCT 2023

Viewpoints From Europe

Presenter: Stephan Windecker

October 24, 2023

Presentation TCT 2022

What Do the Guidelines Say?

Presenter: Stephan Windecker

September 18, 2022

Presentation TCT 2021

Evidence-Based Antiplatelet and Antithrombotic Therapy for TAVR

Presenter: Stephan Windecker

November 05, 2021

Presentation TCT 2019

SELUTION SLR: A Sustained Limus Release Drug-Eluting Balloon — First Human Data From a Multicenter Coronary Trial

Presenter: Stephan Windecker

September 27, 2019

News TCT 2019

TCT 2019 Day One: TWILIGHT and Onyx ONE Kick Things Off

Shelley Wood

September 26, 2019

Presentation TCT 2019

AUGUSTUS ACS: A 2x2 Factorial Randomized Trial of Apixaban vs. Warfarin and Aspirin vs. Placebo in Patients With Atrial Fibrillation and an Acute Coronary Syndrome

Presenter: Stephan Windecker

September 26, 2019

News Conference News TCT 2019

AUGUSTUS: Apixaban-Based Dual Therapy Best Across Major Subgroups

Todd Neale

September 26, 2019

News Conference News TCT 2019

Onyx ONE: Shorter DAPT Plus ZES Noninferior to Polymer-Free Stent in High-Bleeding-Risk Patients

L.A. McKeown

September 26, 2019

Presentation TCT 2019

Onyx ONE: A Randomized Trial of a Durable-Polymer Drug-Eluting Stent vs. a Polymer-Free Drug-Coated Stent in Patients at High Risk of Bleeding Treated With 1-Month DAPT

Presenter: Stephan Windecker

September 26, 2019

Presentation TCT 2019

The High-Bleeding Risk Patient: Current Recommendations and Overview of Dedicated Trials

Presenter: Stephan Windecker

September 26, 2019

Opening Debate: Which Metallic DES Should Be on My Cath Lab Shelf? - Choose Whatever You Want! Most Contemporary DES Display Comparable Clinical Performance!

Presentation TCT 2019

Choose Whatever You Want! Most Contemporary DES Display Comparable Clinical Performance!

Presenter: Stephan Windecker

September 26, 2019

Presentation TCT 2019

Has TAVR Become the Default Therapy in Patients With Severe Aortic Stenosis?

Presenter: Stephan Windecker

September 25, 2019

Presentation TCT 2018

ESC 2018 Late Breaking Trial #2 - MitraFR: What I Liked and What I Question

Presenter: Deepak L. Bhatt, Gregg W. Stone, Stephan Windecker

September 23, 2018

Advertisement

Case-Based Discussion: Designing a Contemporary Cardiovascular Trial

Impact & Utility of a Global Registry Infrastructure for Device Evidence: ESC Regulatory Affairs Committee Perspective

Globalization of Regulatory Requirements: Challenges & Opportunities - A European Perspective

Breakthroughs In Pharmaceuticals: Antagonistic or Synergistic to Innovation in Device Development

Does Polymer Coating Matter? Biodegradable vs Durable vs Polymer-Free

Perspective: How I See the Future for TAVR in Younger Patients With Bicuspid AS

Some Surprises in Low-Risk TAVI Follow-up: PARTNER 3 and Evolut Trials

Viewpoints From Europe

What Do the Guidelines Say?

Evidence-Based Antiplatelet and Antithrombotic Therapy for TAVR

SELUTION SLR: A Sustained Limus Release Drug-Eluting Balloon — First Human Data From a Multicenter Coronary Trial

TCT 2019 Day One: TWILIGHT and Onyx ONE Kick Things Off

AUGUSTUS ACS: A 2x2 Factorial Randomized Trial of Apixaban vs. Warfarin and Aspirin vs. Placebo in Patients With Atrial Fibrillation and an Acute Coronary Syndrome

AUGUSTUS: Apixaban-Based Dual Therapy Best Across Major Subgroups

Onyx ONE: Shorter DAPT Plus ZES Noninferior to Polymer-Free Stent in High-Bleeding-Risk Patients

Onyx ONE: A Randomized Trial of a Durable-Polymer Drug-Eluting Stent vs. a Polymer-Free Drug-Coated Stent in Patients at High Risk of Bleeding Treated With 1-Month DAPT

The High-Bleeding Risk Patient: Current Recommendations and Overview of Dedicated Trials

Choose Whatever You Want! Most Contemporary DES Display Comparable Clinical Performance!

Has TAVR Become the Default Therapy in Patients With Severe Aortic Stenosis?

ESC 2018 Late Breaking Trial #2 - MitraFR: What I Liked and What I Question

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content